Retrospective Palivizumab Study in Children With Hemodynamically Significant Congenital Heart Disease

Site Reference ID/Investigator# 7956, Vienna

Site Reference ID/Investigator# 9403, Vienna

Site Reference ID/Investigator# 17821, Brussels

Site Reference ID/Investigator# 14682, Ljubljana

Site Reference ID/Investigator# 18601, Leuven

Site Reference ID/Investigator# 6263, Linz

Site Reference ID/Investigator# 14802, Trondheim

Site Reference ID/Investigator# 18602, Ghent

Site Reference ID/Investigator# 9621, Berlin

Site Reference ID/Investigator# 5372, A Coruña

Site Reference ID/Investigator# 15261, Santiago de Compostela

Site Reference ID/Investigator# 11182, Rostock

Site Reference ID/Investigator# 15381, Madrid

Site Reference ID/Investigator# 15702, Madrid

Site Reference ID/Investigator# 6280, Bad Oeynhausen

Site Reference ID/Investigator# 4910, Padua

Site Reference ID/Investigator# 6271, Göttingen

Site Reference ID/Investigator# 16361, Braunschweig

Site Reference ID/Investigator# 6244, Nantes

Site Reference ID/Investigator# 6272, Essen

Site Reference ID/Investigator# 6283, Duisburg

Site Reference ID/Investigator# 6276, Florence

Site Reference ID/Investigator#6260, Reims

Site Reference ID/Investigator# 6249, Sankt Augustin

Site Reference ID/Investigator# 6261, Paris

Site Reference ID/Investigator# 4703, Naples

Site Reference ID/Investigator# 8277, Munich

Site Reference ID/Investigator# 6274, Campobasso

Site Reference ID/Investigator# 6245, Paris

Site Reference ID/Investigator# 14681, Roma

Site Reference ID/Investigator# 6275, Bydgoszcz

Site Reference ID/Investigator# 13102, Katowice

Site Reference ID/Investigator# 6270, Krakow

Site Reference ID/Investigator# 12222, Warsaw

Site Reference ID/Investigator# 6282, Belfast

Site Reference ID/Investigator# 13941, Bristol

Site Reference ID/Investigator# 5023, London